FI852657A7 - Heterosyklisiä farmaseuttisia yhdisteitä, valmistus ja käyttö. - Google Patents

Heterosyklisiä farmaseuttisia yhdisteitä, valmistus ja käyttö. Download PDF

Info

Publication number
FI852657A7
FI852657A7 FI852657A FI852657A FI852657A7 FI 852657 A7 FI852657 A7 FI 852657A7 FI 852657 A FI852657 A FI 852657A FI 852657 A FI852657 A FI 852657A FI 852657 A7 FI852657 A7 FI 852657A7
Authority
FI
Finland
Prior art keywords
preparation
pharmaceutical compounds
heterocyclic pharmaceutical
heterocyclic
compounds
Prior art date
Application number
FI852657A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI852657L (fi
FI852657A0 (fi
Inventor
Nariman Bomanshaw Mehta
Thomas Edgar Smyser
Original Assignee
The Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Ltd filed Critical The Wellcome Foundation Ltd
Publication of FI852657A0 publication Critical patent/FI852657A0/fi
Publication of FI852657L publication Critical patent/FI852657L/fi
Publication of FI852657A7 publication Critical patent/FI852657A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI852657A 1984-07-05 1985-07-04 Heterosyklisiä farmaseuttisia yhdisteitä, valmistus ja käyttö. FI852657A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848417170A GB8417170D0 (en) 1984-07-05 1984-07-05 Heterocyclic pharmaceutical compounds

Publications (3)

Publication Number Publication Date
FI852657A0 FI852657A0 (fi) 1985-07-04
FI852657L FI852657L (fi) 1986-01-06
FI852657A7 true FI852657A7 (fi) 1986-01-06

Family

ID=10563453

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852657A FI852657A7 (fi) 1984-07-05 1985-07-04 Heterosyklisiä farmaseuttisia yhdisteitä, valmistus ja käyttö.

Country Status (12)

Country Link
EP (1) EP0170430A1 (show.php)
JP (1) JPS6124578A (show.php)
KR (1) KR860001083A (show.php)
AU (1) AU4459585A (show.php)
DK (1) DK307385A (show.php)
ES (1) ES8609286A1 (show.php)
FI (1) FI852657A7 (show.php)
GB (1) GB8417170D0 (show.php)
GR (1) GR851645B (show.php)
HU (1) HUT39437A (show.php)
IL (1) IL75720A0 (show.php)
ZA (1) ZA855072B (show.php)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
US7098206B2 (en) 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
BR9907203A (pt) 1998-01-21 2000-10-17 Glaxo Group Ltd "composto, composições farmacêuticas, uso de um composto, e, processo de tratametno de depressão, distúrbio de hiperatividade por deficiência de atenção (adhd), obesidade, enxaqueca, dor, disfunção sexual, doença de parkinson, doença de alzeheimer, ou vìcio de cocaìna ou de produtos contendo nicotina (especialmente tabaco) em um indivìduo animal ou humano. "
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
KR101014438B1 (ko) * 2008-09-26 2011-02-14 동아제약주식회사 탁산 유도체의 제조방법
CA2800220C (en) 2010-05-21 2019-04-30 Research Triangle Institute Phenylmorpholines and analogues thereof
CA2800219C (en) 2010-05-21 2019-03-12 Research Triangle Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
JPS6124578A (ja) 1986-02-03
ES8609286A1 (es) 1986-07-16
GB8417170D0 (en) 1984-08-08
EP0170430A1 (en) 1986-02-05
KR860001083A (ko) 1986-02-22
DK307385A (da) 1986-01-06
ES544862A0 (es) 1986-07-16
FI852657L (fi) 1986-01-06
HUT39437A (en) 1986-09-29
AU4459585A (en) 1986-01-09
FI852657A0 (fi) 1985-07-04
DK307385D0 (da) 1985-07-04
GR851645B (show.php) 1985-11-26
IL75720A0 (en) 1985-11-29
ZA855072B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
FI853626A7 (fi) Isoksatsolikarboksyylihappojohdannaiset, niiden valmistus ja käyttö.
NL300038I2 (nl) Thiazolidinedionderivaten, alsmede bereiding en toepassing daarvan.
FI863362L (fi) Farmaceutisk sammansaettning.
DE3580304D1 (de) Arzneimittel.
FI831457A7 (fi) 1-sulfo-2-atsetidinon-johdannaiset, niiden valmistus ja käyttö.
DE3685170D1 (de) Histaminderivate enthaltende pharmazeutische zusammensetzung.
FI873010A7 (fi) Nitrofuraanijohdannaiset, niiden valmistus ja niiden terapeuttinen sovellutus.
FI845117A7 (fi) Uudet 2-fenyyli-imidatsolit, niiden valmistaminen ja näitä yhdisteitä sisältävät lääkeaineet.
FI854573A0 (fi) Farmaceutiska kapslar med foerdroejd frigoering.
FI860369A7 (fi) Imidatsolijohdannaisia, niiden valmistus ja käyttö, sekä näitä johdannaisia sisältävät farmaseuttisetkoostumukset.
FI820509A7 (fi) Uusia atsepiinijohdoksia, niiden valmistus ja niiden käyttö lääkeaineina.
FI885811A7 (fi) Uudet ammoniumyhdisteet, niiden valmistus ja käyttö
FI851924A7 (fi) Uudet bentsatsepiinijohdokset, näitä yhdisteitä sisältävät lääkeaineet ja näiden valmistusmenetelmä.
FI803356A7 (fi) Uudet atsepinoindolit, niiden valmistus ja niitä sisältävät farmaseuttiset yhdisteet.
IT8621192A0 (it) Composizione farmaceutica.
DK219685D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
FI853698A7 (fi) Pyrimidiinijohdokset, menetelmä niiden valmistamiseksi ja näiden seokset.
ZA855072B (en) Heterocyclic pharmaceutical compounds,preparation and use
IT8548385A0 (it) Composti maftalenici,loro preparazi one e loro impiego come medicamenti
DK133587A (da) 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne
FI852647A7 (fi) 3-aminokarbonyylimetoksi-5 -fenyylipyratsoliyhdisteet ja niiden valmistusmenetelmä sekä näitä yhdisteitä sisältävät lääkeaineet.
FI852658A7 (fi) Farmaseuttiset aineet.
DE3588036D1 (de) 5-Fluoruracilderivate.
FI853621A7 (fi) Vinyylitetrasolyylifenyyli-johdannaisia, niiden valmistus ja käyttö.
FI810835A7 (fi) Uusia tioformamidijohdannaisia, niiden valmistaminen ja niitä sisältävät lääkkeet.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED